The prevalence of nonalcoholic fatty liver disease in the Americas.
about
Role of bioactive fatty acids in nonalcoholic fatty liver diseaseThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseNonalcoholic fatty liver disease - A multisystem disease?Sirtuins and nonalcoholic fatty liver diseaseObesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.The VASP Road to NAFLD: A Macrophage DetourBidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewGlobal Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority PopulationsGenetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013.Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America.Non-alcoholic Fatty Liver Disease: A Clinical Update.Biliverdin Reductase and Bilirubin in Hepatic Disease.Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.Death by Carbs: Added Sugars and Refined Carbohydrates Cause Diabetes and Cardiovascular Disease in Asian IndiansSystems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
P2860
Q26739904-F5AB1B9D-7E03-4D95-A227-476D29419A25Q26784452-118F19A7-2F75-45A3-B89B-D18DDEFE9314Q28079077-532B976C-3878-4826-AAF0-9E891C51B4A0Q28079953-2A88BAF0-F012-4635-A982-9787D461B772Q33580624-76E365F5-4DCD-462B-8E81-6AC25BA1C31FQ34698101-ACB16A39-AD5D-4954-9A91-BCB643505175Q35881766-8F144B28-4952-470A-AAF9-083E0182C383Q36325487-4B6F70AB-4B7A-4958-BE14-A5615BC32E9DQ36369189-D0EF3EDE-D069-4198-95B1-E77E1D9DB912Q36818424-37F7FB82-51DC-4ED5-9A15-E006D75BEA30Q37146192-BB1BE9F4-C7C7-4A5F-9E35-24E48FF61DBAQ37609569-7B989184-13E8-446B-AAAB-8F53514D0CD8Q41430210-17475D22-4FC4-4ADA-A890-6027D82352ABQ42350815-1DB1558F-BA84-462C-99B0-17197FCEBAF7Q45329335-AA0D4F99-5943-4582-ABF1-D2A6AA6077C9Q47100244-9A784B3C-EB58-42DA-BC6D-E53BA5CA8CACQ52679682-1D94C879-2D7B-4F30-AC41-4257CB8E4A33Q55092410-63E67623-3374-4E09-8C4D-04F9BCFFF44CQ57939070-480B4398-5D3D-42FF-9F2A-0E49FDBD4C09Q58747347-183B420D-6CE7-4E90-9F22-C4BD5D5B6C1D
P2860
The prevalence of nonalcoholic fatty liver disease in the Americas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The prevalence of nonalcoholic fatty liver disease in the Americas.
@en
type
label
The prevalence of nonalcoholic fatty liver disease in the Americas.
@en
prefLabel
The prevalence of nonalcoholic fatty liver disease in the Americas.
@en
P2093
P1476
The prevalence of nonalcoholic fatty liver disease in the Americas.
@en
P2093
Guadalupe Ponciano-Rodríguez
Jorge A López-Velázquez
Karen V Silva-Vidal
Marco Arrese
Nahum Méndez-Sánchez
P304
P577
2014-03-01T00:00:00Z